The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial

BACKGROUND: In nephrotic syndrome, the combination of furosemide and albumin infusion is a standard regimen to treat systemic edema. The efficacy of synthetic human atrial natriuretic peptide (hANP) for nephrotic syndrome to ameliorate the systemic edema and retain renal functions has not been fully...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kanzaki, Motoko, Wada, Jun, Kikumoto, Yoko, Akagi, Shigeru, Nakao, Kazushi, Sugiyama, Hitoshi, Makino, Hirofumi
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2012
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379862/
https://ncbi.nlm.nih.gov/pubmed/22723729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S32191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky